Ladenburg Thalmann Downgrades CryoLife (CRY) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. AXP
9. ZETA
10. DAL

Go back to Ladenburg Thalmann Downgrades CryoLife (CRY) to Neutral

CryoLife Reports First Quarter 2016 Financial Results

April 27, 2016 5:34 PM EDT

ATLANTA, April 27, 2016 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today its results for the first quarter of 2016. 

Recent Highlights:

First Quarter Revenue Increased 27 Percent Year-over-Year to $43.0 Million; Pro Forma Revenues Increased Nine Percent Year-over-Year Strengthened Focus on Cardiac Surgery Technologies and Enhanced Growth Potential Through Strategic Initiatives, including: Acquisition of On-X® Life Technologies (On-X) Sale of HeRO® Graft Product Line Sale of ProCol®... More